Skip to main content

Table 2 Occurrence of ocular hyperemia by severity grade

From: Tolerability and efficacy of bimatoprost 0.01 % in patients with open-angle glaucoma or ocular hypertension evaluated in the Taiwanese clinical setting: the Asia Pacific Patterns from Early Access of Lumigan 0.01 % (APPEAL Taiwan) study

 

Treatment-naïve

(n = 42)

Previously treated

(n = 270)

Assessment visit

Baseline

Week 12

Baseline

Week 12

Missing data, n (%)

0

8 (19.0)

0

30 (11.1)

Hyperemia grading, n (%)

 0 (none, normal)

13 (31.0)

7 (20.6)

39 (14.4)

36 (15.0)

  +0.5 (trace)

12 (28.6)

10 (29.4)

70 (25.9)

50 (20.8)

  +1 (mild)

11 (26.2)

12 (35.3)

92 (34.1)

84 (35.0)

  +2 (moderate)

6 (14.3)

5 (14.7)

57 (21.1)

59 (24.6)

  +3 (severe)

0

0

12 (4.4)

11 (4.6)